Moschetta A - Search Results

1

Metabolic Messengers: fibroblast growth factor 15/19.

Gadaleta RM, Moschetta A. Gadaleta RM, et al. Among authors: moschetta a. Nat Metab. 2019 Jun;1(6):588-594. doi: 10.1038/s42255-019-0074-3. Epub 2019 Jun 14. Nat Metab. 2019. PMID: 32694803 Review.

2

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.

Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA. Inagaki T, et al. Among authors: moschetta a. Cell Metab. 2005 Oct;2(4):217-25. doi: 10.1016/j.cmet.2005.09.001. Cell Metab. 2005. PMID: 16213224 Free article.

3

Welcoming Foxa2 in the bile acid entourage.

Moschetta A. Moschetta A. Cell Metab. 2008 Oct;8(4):276-8. doi: 10.1016/j.cmet.2008.09.009. Cell Metab. 2008. PMID: 18840356 Free article.

4

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.

Gadaleta RM, van Erpecum KJ, Oldenburg B, Willemsen EC, Renooij W, Murzilli S, Klomp LW, Siersema PD, Schipper ME, Danese S, Penna G, Laverny G, Adorini L, Moschetta A, van Mil SW. Gadaleta RM, et al. Among authors: moschetta a. Gut. 2011 Apr;60(4):463-72. doi: 10.1136/gut.2010.212159. Epub 2011 Jan 17. Gut. 2011. PMID: 21242261

5

Deciphering the nuclear bile acid receptor FXR paradigm.

Modica S, Gadaleta RM, Moschetta A. Modica S, et al. Among authors: moschetta a. Nucl Recept Signal. 2010 Nov 19;8:e005. doi: 10.1621/nrs.08005. Nucl Recept Signal. 2010. PMID: 21383957 Free PMC article. Review.

6

Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver.

Cicione C, Degirolamo C, Moschetta A. Cicione C, et al. Among authors: moschetta a. Hepatology. 2012 Dec;56(6):2404-11. doi: 10.1002/hep.25929. Hepatology. 2012. PMID: 22753116 Review.

7

Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice.

Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. Degirolamo C, et al. Among authors: moschetta a. Cell Rep. 2014 Apr 10;7(1):12-8. doi: 10.1016/j.celrep.2014.02.032. Epub 2014 Mar 20. Cell Rep. 2014. PMID: 24656817 Free article.

8

Fibroblast growth factor 21: a new liver safeguard.

Cariello M, Moschetta A. Cariello M, et al. Among authors: moschetta a. Hepatology. 2014 Sep;60(3):792-4. doi: 10.1002/hep.27147. Epub 2014 May 9. Hepatology. 2014. PMID: 24668840 No abstract available.

9

Tissue-specific actions of FXR in metabolism and cancer.

Gadaleta RM, Cariello M, Sabbà C, Moschetta A. Gadaleta RM, et al. Among authors: moschetta a. Biochim Biophys Acta. 2015 Jan;1851(1):30-9. doi: 10.1016/j.bbalip.2014.08.005. Epub 2014 Aug 17. Biochim Biophys Acta. 2015. PMID: 25139561 Review.

10

Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.

Degirolamo C, Sabbà C, Moschetta A. Degirolamo C, et al. Among authors: moschetta a. Nat Rev Drug Discov. 2016 Jan;15(1):51-69. doi: 10.1038/nrd.2015.9. Epub 2015 Nov 16. Nat Rev Drug Discov. 2016. PMID: 26567701 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page